23 May 2024 : Database Analysis
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB
Yongyuan Zheng1ABCD, Yansong Huang1CDE, Weibing Li1CD, Hongqiu Cheng1AEG*DOI: 10.12659/MSM.944685
Med Sci Monit 2024; 30:e944685
Figure 4 Diagnostic value of MRTO4 expression in hepatocellular carcinoma. (A) Receiver operating characteristic (ROC) curve analysis for MRTO4 expression in HCC and adjacent tissue. (B) Time-dependent survival ROC analysis for MRTO4 expression in HCC and adjacent tissue to predict 1-, 3-, and 5-year survival rates. (C) Time-dependent AUC curve analysis for MRTO4 expression in HCC and adjacent tissue. (D) Calibration plots of the nomogram for predicting the probability of OS at 1, 3, and 5 years. (E) Nomogram survival prediction chart for predicting the 1-, 3-, and 5-year overall survival rates.